Insider Transactions Reported by 13 Insiders of ACTUATE THERAPEUTICS, INC.

Symbol
ACTU on Nasdaq
Location
Fort Worth, TX

Insiders trading volume in the past year

ACTUATE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Leslie W. Kreis Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Bios Equity COF, LP Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
TODD S. THOMSON Director, 10%+ Owner $16,003,463 -$1,624,000 -9.2% 05 Jan 2026
DANIEL M. SCHMITT President, CEO and Director, Director $4,851,010 13 Feb 2026
Roger Sawhney Director 22 May 2025
AMY L. RONNEBERG Director 22 May 2025
Jason A. Keyes Director 22 May 2025
Andrew Paul Mazar Chief Operating Officer 01 Apr 2025
Bios 2024 Co-Invest, LP Director, Member of 10% Group 14 Aug 2024
Bios Clinical Opportunity Fund, LP 10%+ Owner 12 Aug 2024
PAUL J. LYTLE Chief Financial Officer 01 Apr 2025
Dan Zabrowski Director 22 May 2025

Recent Insider Transactions by Companies or Individuals for ACTUATE THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
DANIEL M. SCHMITT ACTU Common Stock Tax liability -44.8% -121,874 150,181 13 Feb 2026 Direct
DANIEL M. SCHMITT ACTU Common Stock Options Exercise 272,055 272,055 13 Feb 2026 Direct
DANIEL M. SCHMITT ACTU Restricted Stock Units Options Exercise -50% -272,055 272,056 13 Feb 2026 Direct
TODD S. THOMSON ACTU Common Stock Sale -23.6% $1,624,000 $5.80 -280,000 904,795 05 Jan 2026 By Kairos Venture Partners II, L.P.
Bios Equity COF, LP ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Bios Equity COF, LP ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Leslie W. Kreis ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Leslie W. Kreis ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Aaron G.L. Fletcher ACTU Common Stock Purchase 57.1% $499,996 $7.00 71,428 196,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
Aaron G.L. Fletcher ACTU Warrant (Right to Buy) Purchase 71,428 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
TODD S. THOMSON ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Roger Sawhney ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Dan Zabrowski ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Aaron G.L. Fletcher ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
Jason A. Keyes ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
AMY L. RONNEBERG ACTU Stock Options Award 15,000 15,000 22 May 2025 Direct
DANIEL M. SCHMITT ACTU Employee Stock Option (right to buy) Award 270,788 204,285 01 Apr 2025 Direct
Andrew Paul Mazar ACTU Employee Stock Option (right to buy) Award 161,392 110,346 01 Apr 2025 Direct
PAUL J. LYTLE ACTU Employee Stock Option (right to buy) Award 91,293 49,394 01 Apr 2025 Direct
Bios Equity COF, LP ACTU Common Stock Sale -1.74% -2,324 131,248 14 Aug 2024 Directly held by Bios Fund II NT, LP
Bios Equity COF, LP ACTU Common Stock Sale -1.74% -17,361 980,433 14 Aug 2024 Directly held by Bios Fund II QP, LP
Bios Equity COF, LP ACTU Common Stock Sale -1.74% -5,314 300,143 14 Aug 2024 Directly held by Bios Fund II, LP
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -2,324 131,248 14 Aug 2024 Directly held by Bios Fund II NT, LP
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -17,361 980,433 14 Aug 2024 Directly held by Bios Fund II QP, LP
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -5,314 300,143 14 Aug 2024 Directly held by Bios Fund II, LP
Leslie W. Kreis ACTU Common Stock Sale -1.74% -2,324 131,248 14 Aug 2024 Directly held by Bios Fund II NT, LP
Leslie W. Kreis ACTU Common Stock Sale -1.74% -17,361 980,433 14 Aug 2024 Directly held by Bios Fund II QP, LP
Leslie W. Kreis ACTU Common Stock Sale -1.74% -5,314 300,143 14 Aug 2024 Directly held by Bios Fund II, LP
TODD S. THOMSON ACTU Common Stock Sale -1.56% -18,750 1,184,795 14 Aug 2024 By KVP II, L.P.
TODD S. THOMSON ACTU Common Stock Exercise of in-the-money or at-the-money derivative security 2.42% 28,464 1,203,545 14 Aug 2024 By KVP II, L.P.
TODD S. THOMSON ACTU Common Stock Conversion of derivative security 254,735 254,735 14 Aug 2024 By Kairos-Actuate SPV, L.P.
TODD S. THOMSON ACTU Common Stock Conversion of derivative security 321,781 321,781 14 Aug 2024 By Kairos SPV Fund, LLC
TODD S. THOMSON ACTU Common Stock Conversion of derivative security 873,033 873,033 14 Aug 2024 By KVOI, L.P.
TODD S. THOMSON ACTU Common Stock Conversion of derivative security 2383.4% 1,127,763 1,175,081 14 Aug 2024 By KVP II, L.P.
TODD S. THOMSON ACTU Warrant (Right to Buy) Exercise of in-the-money or at-the-money derivative security 28,464 0 14 Aug 2024 By KVP II, L.P.
TODD S. THOMSON ACTU Series C Redeemable Convertible Preferred Stock Conversion of derivative security 49,984 0 14 Aug 2024 By Kairos SPV Fund, LLC
TODD S. THOMSON ACTU Series C Redeemable Convertible Preferred Stock Conversion of derivative security 24,138 0 14 Aug 2024 By Kairos-Actuate SPV, L.P.
TODD S. THOMSON ACTU Series B-4 Redeemable Convertible Preferred Stock Conversion of derivative security 132,908 0 14 Aug 2024 By Kairos SPV Fund, LLC
TODD S. THOMSON ACTU Series B-4 Redeemable Convertible Preferred Stock Conversion of derivative security 230,597 0 14 Aug 2024 By Kairos-Actuate SPV, L.P.
TODD S. THOMSON ACTU Series B-3 Redeemable Convertible Preferred Stock Conversion of derivative security 138,889 0 14 Aug 2024 By Kairos SPV Fund, LLC
TODD S. THOMSON ACTU Series B-3 Redeemable Convertible Preferred Stock Conversion of derivative security 146,870 0 14 Aug 2024 By KVOI, L.P.
TODD S. THOMSON ACTU Series B-3 Redeemable Convertible Preferred Stock Conversion of derivative security 69,445 0 14 Aug 2024 By KVP II, L.P.
TODD S. THOMSON ACTU Series B-2 Redeemable Convertible Preferred Stock Conversion of derivative security 726,163 0 14 Aug 2024 By KVOI, L.P.
TODD S. THOMSON ACTU Series B-1 Redeemable Convertible Preferred Stock Conversion of derivative security 1,058,318 0 14 Aug 2024 By KVP II, L.P.
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -2,324 131,248 14 Aug 2024 Directly held by Bios Fund II NT, LP
Aaron G.L. Fletcher ACTU Common Stock Exercise of in-the-money or at-the-money derivative security 2.71% 3,528 133,572 14 Aug 2024 Directly held by Bios Fund II NT, LP
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -17,361 980,433 14 Aug 2024 Directly held by Bios Fund II QP, LP
Aaron G.L. Fletcher ACTU Common Stock Exercise of in-the-money or at-the-money derivative security 2.71% 26,355 997,794 14 Aug 2024 Directly held by Bios Fund II QP, LP
Aaron G.L. Fletcher ACTU Common Stock Sale -1.74% -5,314 300,143 14 Aug 2024 Directly held by Bios Fund II, LP
Aaron G.L. Fletcher ACTU Common Stock Exercise of in-the-money or at-the-money derivative security 2.71% 8,068 305,457 14 Aug 2024 Directly held by Bios Fund II, LP
* An asterisk sign (*) next to the price indicates that the price is likely invalid.